Vinoth‐Kumar Lakshmanan

3.7k total citations
59 papers, 2.3k citations indexed

About

Vinoth‐Kumar Lakshmanan is a scholar working on Molecular Biology, Biomaterials and Molecular Medicine. According to data from OpenAlex, Vinoth‐Kumar Lakshmanan has authored 59 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 22 papers in Biomaterials and 9 papers in Molecular Medicine. Recurrent topics in Vinoth‐Kumar Lakshmanan's work include Nanoparticle-Based Drug Delivery (14 papers), RNA Interference and Gene Delivery (9 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Vinoth‐Kumar Lakshmanan is often cited by papers focused on Nanoparticle-Based Drug Delivery (14 papers), RNA Interference and Gene Delivery (9 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Vinoth‐Kumar Lakshmanan collaborates with scholars based in India, South Korea and United Arab Emirates. Vinoth‐Kumar Lakshmanan's co-authors include R. Jayakumar, Shantikumar V. Nair, P.T. Sudheesh Kumar, K. S. Snima, Raja Biswas, A. Anitha, K.P. Chennazhi, N. Sanoj Rejinold, Vibha Rani and Sabitha Mangalathillam and has published in prestigious journals such as Scientific Reports, ACS Applied Materials & Interfaces and Nanoscale.

In The Last Decade

Vinoth‐Kumar Lakshmanan

59 papers receiving 2.2k citations

Peers

Vinoth‐Kumar Lakshmanan
Hnin Ei Thu Malaysia
Vinoth‐Kumar Lakshmanan
Citations per year, relative to Vinoth‐Kumar Lakshmanan Vinoth‐Kumar Lakshmanan (= 1×) peers Hnin Ei Thu

Countries citing papers authored by Vinoth‐Kumar Lakshmanan

Since Specialization
Citations

This map shows the geographic impact of Vinoth‐Kumar Lakshmanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinoth‐Kumar Lakshmanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinoth‐Kumar Lakshmanan more than expected).

Fields of papers citing papers by Vinoth‐Kumar Lakshmanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinoth‐Kumar Lakshmanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinoth‐Kumar Lakshmanan. The network helps show where Vinoth‐Kumar Lakshmanan may publish in the future.

Co-authorship network of co-authors of Vinoth‐Kumar Lakshmanan

This figure shows the co-authorship network connecting the top 25 collaborators of Vinoth‐Kumar Lakshmanan. A scholar is included among the top collaborators of Vinoth‐Kumar Lakshmanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinoth‐Kumar Lakshmanan. Vinoth‐Kumar Lakshmanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rather, Gulzar Ahmed, et al.. (2024). Facile synthesis of elastin nanogels encapsulated decursin for castrated resistance prostate cancer therapy. Scientific Reports. 14(1). 15095–15095. 8 indexed citations
2.
Rajan, Prabhakar, et al.. (2024). Prostate cancer theragnostics biomarkers: An update. Investigative and Clinical Urology. 65(6). 527–527. 11 indexed citations
3.
Li, Shinan, Thi Thinh Nguyen, Trong Thuan Ung, et al.. (2022). Piperine Attenuates Lithocholic Acid-Stimulated Interleukin-8 by Suppressing Src/EGFR and Reactive Oxygen Species in Human Colorectal Cancer Cells. Antioxidants. 11(3). 530–530. 19 indexed citations
4.
Lakshmanan, Vinoth‐Kumar, P. Gopinath, Shreesh Ojha, et al.. (2021). Nanomedicine-based cancer immunotherapy: recent trends and future perspectives. Cancer Gene Therapy. 28(9). 911–923. 60 indexed citations
6.
Lakshmanan, Vinoth‐Kumar, Shreesh Ojha, & Young Do Jung. (2020). A modern era of personalized medicine in the diagnosis, prognosis, and treatment of prostate cancer. Computers in Biology and Medicine. 126. 104020–104020. 15 indexed citations
7.
Nair, Shantikumar V., et al.. (2016). Leucas aspera Nanomedicine Shows Superior Toxicity and Cell Migration Retarded in Prostate Cancer Cells. Applied Biochemistry and Biotechnology. 181(4). 1388–1400. 12 indexed citations
8.
Snima, K. S., et al.. (2015). Biocompatibility studies of pectin-fibrin nanocomposite bearing BALB/c mice. Cellulose Chemistry and Technology. 49. 1 indexed citations
9.
Nair, Harikrishnan S., et al.. (2015). Plumbagin Nanoparticles Induce Dose and pH Dependent Toxicity on Prostate Cancer Cells.. Current Drug Delivery. 12(6). 709–716. 16 indexed citations
10.
Anitha, A., N. Deepa, K.P. Chennazhi, Vinoth‐Kumar Lakshmanan, & R. Jayakumar. (2014). Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment. Biochimica et Biophysica Acta (BBA) - General Subjects. 1840(9). 2730–2743. 134 indexed citations
11.
Anitha, A., et al.. (2014). In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies. European Journal of Pharmaceutics and Biopharmaceutics. 88(1). 238–251. 121 indexed citations
12.
Snima, K. S., R. Jayakumar, & Vinoth‐Kumar Lakshmanan. (2014). In Vitro and In Vivo Biological Evaluation of O-Carboxymethyl Chitosan Encapsulated Metformin Nanoparticles for Pancreatic Cancer Therapy. Pharmaceutical Research. 31(12). 3361–3370. 31 indexed citations
13.
Snima, K. S., et al.. (2014). Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy. Current Cancer Drug Targets. 14(8). 727–736. 21 indexed citations
14.
Kumar, P.T. Sudheesh, et al.. (2013). Drug delivery and tissue engineering applications of biocompatible pectin–chitin/nano CaCO3 composite scaffolds. Colloids and Surfaces B Biointerfaces. 106. 109–116. 57 indexed citations
15.
Praveen, G., K. S. Snima, Shantikumar V. Nair, et al.. (2013). Potential Use of Drug Loaded Nano Composite Pectin Scaffolds for the Treatment of Ovarian Cancer. Current Drug Delivery. 10(3). 326–335. 13 indexed citations
16.
Sabitha, M., et al.. (2012). Development and evaluation of 5-fluorouracil loaded chitin nanogels for treatment of skin cancer. Carbohydrate Polymers. 91(1). 48–57. 100 indexed citations
17.
Kumar, P.T. Sudheesh, et al.. (2012). Evaluation of Wound Healing Potential of β-Chitin Hydrogel/Nano Zinc Oxide Composite Bandage. Pharmaceutical Research. 30(2). 523–537. 116 indexed citations
18.
Mangalathillam, Sabitha, et al.. (2011). Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale. 4(1). 239–250. 220 indexed citations
19.
Kumar, P.T. Sudheesh, S. Sowmya, Vinoth‐Kumar Lakshmanan, et al.. (2011). Synthesis, characterization and cytocompatibility studies of α-chitin hydrogel/nano hydroxyapatite composite scaffolds. International Journal of Biological Macromolecules. 49(1). 20–31. 57 indexed citations
20.
Bu, Huajie, Georg Schäfer, Wolfgang Horninger, et al.. (2010). The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection. The Prostate. 71(6). 575–587. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026